• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Cynosure Acquires Palomar Medical Technologies

Share:

December 10, 2018

Cynosure Inc., a Westford, Mass.-based medical laser technology company, is acquiring Palomar Medical Technologies Inc. for $294 million. Palomar is focused on the same technology as Cynosure, which typically is used for cosmetic and plastic surgeries, and is based in Burlington, Mass.

Cynosure expects the acquisition to effectively function as an expansion of its existing portfolio and customer base. The acquisition also will add more than 40 patents in Cynosure’s portfolio, thereby boosting its intellectual property position.

Under terms of the deal, Cynosure will issue 5.2 million shares, which will bring in approximately $120 million. The rest of the purchase price will be made through existing cash reserves. The purchase price is at a premium of 23 percent above Palomar’s average closing price, and 34 percent above the company’s average enterprise value, according to its reported 2012 fiscal results.

Both company’s boards of directors have voted unanimously in favor of the deal, which is expected to close by the end of this year. Cynosure officials have reported that there are some projects in the works that will be accretive to its 2014 performance. Post-acquisition, the cash balance of the company is expected to be around $87 million and it will remain debt-free, officials said.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Together, Cynosure and Palomar reportedly have an installed base of more than 20,000 aesthetic laser systems with a distribution network across more than 100 countries worldwide. The collective revenue for both companies in fiscal 2012 was $234 million, of which 52 percent was attributable to North America and the rest from the international markets.

Cynosure makes non-invasive and minimally invasive products to rejuvenate skin, treat vascular and benign pigmented lesions, reduce cellulite, remove hair and treat onychomycosis (a fungal infection of the nail).

Date: December 10, 2018

Source: MPO

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Hospital’s Telehealth Program Reduces ER Visits, Treatment CostsHospital’s Telehealth Program Reduces ER Visits, Treatment Costs
  • Plastic Healthcare Packaging Market Recorded Strong Growth in 2019; Covid-19 Pandemic Set to Drop SalesPlastic Healthcare Packaging Market Recorded Strong Growth in 2019; Covid-19 Pandemic Set to Drop Sales
  • 23andMe Receives FDA Clearance for Genetic Test for Prostate Cancer Marker23andMe Receives FDA Clearance for Genetic Test for Prostate Cancer Marker
  • Lilly Announces Agreement To Acquire Loxo OncologyLilly Announces Agreement To Acquire Loxo Oncology
  • Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc.Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc.
  • Amazon Closes $3.9B Acquisition of One MedicalAmazon Closes $3.9B Acquisition of One Medical
  • Thermo Fisher Scientific Completes Acquisition of Advanced Bioprocessing from BDThermo Fisher Scientific Completes Acquisition of Advanced Bioprocessing from BD
  • Imprivata, Vocera Collaborate on Mobile Device AuthenticationImprivata, Vocera Collaborate on Mobile Device Authentication

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications